Genetic/familial high-risk assessment: Colorectal, version 2.2019: Featured updates to the NCCN Guidelines Guidelines


Authors: Gupta, S.; Provenzale, D.; Llor, X.; Halverson, A. L.; Grady, W.; Chung, D. C.; Haraldsdottir, S.; Markowitz, A. J.; Slavin, T. P. Jr; Hampel, H.; Ness, R. M.; Weiss, J. M.; Ahnen, D. J.; Chen, L. M.; Cooper, G.; Early, D. S.; Giardiello, F. M.; Hall, M. J.; Hamilton, S. R.; Kanth, P.; Klapman, J. B.; Lazenby, A. J.; Lynch, P. M.; Mayer, R. J.; Mikkelson, J.; Peter, S.; Regenbogen, S. E.; Dwyer, M. A.; Ogba, N.
Title: Genetic/familial high-risk assessment: Colorectal, version 2.2019: Featured updates to the NCCN Guidelines
Abstract: Identifying individuals with hereditary syndromes allows for improved cancer surveillance, risk reduction, and optimized management. Establishing criteria for assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the assessment and management of patients with high-risk colorectal cancer syndromes. These NCCN Guidelines Insights focus on criteria for the evaluation of Lynch syndrome and considerations for use of multigene testing in the assessment of hereditary colorectal cancer syndromes. © National Comprehensive Cancer Network, Inc. 2019. All rights reserved.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 17
Issue: 9
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2019-09-01
Start Page: 1032
End Page: 1041
Language: English
DOI: 10.6004/jnccn.2019.0044
PUBMED: 31487681
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 1 October 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Arnold J Markowitz
    138 Markowitz